Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics
Open Access
- 7 February 2024
- journal article
- research article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 28 (1) , 103719
Abstract
No abstract availableKeywords
Funding Information
- CNPq
This publication has 28 references indexed in Scilit:
- 17DD yellow fever vaccineHuman Vaccines & Immunotherapeutics, 2013
- Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodiesBiologicals, 2012
- Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety dataVaccine, 2012
- The early cellular signatures of protective immunity induced by live viral vaccinationEuropean Journal of Immunology, 2012
- Persistence of yellow fever vaccine RNA in urineVaccine, 2011
- Detection of Yellow Fever 17D Genome in UrineJournal of Clinical Microbiology, 2011
- Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adultsVaccine, 2011
- Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinologyNature Reviews Immunology, 2009
- Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected PatientsClinical Infectious Diseases, 2009
- Anamnestic immune response to dengue and decreased severity of yellow feverJournal of Global Infectious Diseases, 2009